Aeterna Zentaris (AEZS) Short Interest Ratio & Short Volume

Short interest is the volume of Aeterna Zentaris shares that have been sold short but have not yet been covered or closed out. As of July 15th, investors have sold 5,300 shares of AEZS short. 0.18% of Aeterna Zentaris' shares are currently sold short. Learn More on Aeterna Zentaris' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.18% of Aeterna Zentaris' floating shares are currently sold short.

Aeterna Zentaris saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 5,300 shares, a decline of 7.0% from the previous total of 5,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Aeterna Zentaris currently has issued a total of 1,793,000 shares. Some of Aeterna Zentaris' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aeterna Zentaris currently has a public float of 3,010,000 shares.

0.18% of Aeterna Zentaris' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aeterna Zentaris: MIRA Pharmaceuticals, Inc. (5.87%), IN8bio, Inc. (1.67%), NRx Pharmaceuticals, Inc. (6.52%), Cyclo Therapeutics, Inc. (0.72%), Alterity Therapeutics Limited (1.76%), Unity Biotechnology, Inc. (1.60%), BioLineRx Ltd. (1.04%), Carisma Therapeutics, Inc. (2.60%), Synlogic, Inc. (1.26%), Spruce Biosciences, Inc. (0.53%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.13 billion), Royal Caribbean Cruises Ltd. ($2.77 billion), Moderna, Inc. ($2.76 billion), Coinbase Global, Inc. ($2.36 billion), Rivian Automotive, Inc. ($2.22 billion), Paychex, Inc. ($2.02 billion), Tractor Supply ($1.81 billion), Enphase Energy, Inc. ($1.65 billion), Chesapeake Energy Co. ($1.62 billion), and Lululemon Athletica Inc. ($1.58 billion). View all of the most shorted stocks.

Short selling AEZS is an investing strategy that aims to generate trading profit from Aeterna Zentaris as its price is falling. AEZS shares are trading down $0.12 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Aeterna Zentaris occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AEZS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AEZS, twice per month. The most recent reporting period available is July, 15 2024.